Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm
Oct 27, 2026
Chemours faces a class action lawsuit alleging overstated Opteon demand compromised financial guidance. Investors purchasing securities between Feb and Aug 2026 are urged to join the case.
Show all 46 updates